One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage All Access membership.
Explore Editage All Access
Open Accesshttps://doi.org/10.1182/blood-2019-124823
Copy DOI Journal: Blood |  Publication Date: Nov 13, 2019 |
 Citations: 3 |
Affiliation: University of Tennessee Health Science Center, University of Illinois at Chicago, University of North Carolina at Chapel Hill, King's College London, Lebanese American University, University of Alabama at Birmingham, Tris Pharma (United States), Assistance Publique – Hôpitaux de Paris, Université Paris-Est CréteilThe Effect of Crizanlizumab Plus Standard of Care (SoC) Versus Soc Alone on Renal Function in Patients with Sickle Cell Disease and Chronic Kidney Disease: A Randomized, Multicenter, Open-Label, Phase II Study (STEADFAST)
Sign-in/Register to access full text options 
Free) Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
